➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
McKinsey
AstraZeneca
Dow
Mallinckrodt

Last Updated: October 29, 2020

DrugPatentWatch Database Preview

Cephalexin - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for cephalexin and what is the scope of freedom to operate?

Cephalexin is the generic ingredient in five branded drugs marketed by Alkem Labs Ltd, Apothecon, Aurobindo Pharma Ltd, Barr, Belcher Pharms, Facta Farma, Hikma, Ivax Sub Teva Pharms, Lupin, Orchid Hlthcare, Purepac Pharm, Stevens J, Sun Pharm Inds (in), Sun Pharm Inds Ltd, Teva, Yoshitomi, Yung Shin Pharm, Pragma, Hikma Pharms, Vitarine, Ranbaxy Labs Ltd, and Lilly, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for cephalexin. Forty suppliers are listed for this compound.

Drug Prices for cephalexin

See drug prices for cephalexin

Drug Sales Revenue Trends for cephalexin

See drug sales revenues for cephalexin

Recent Clinical Trials for cephalexin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Canadian Association of Emergency PhysiciansEarly Phase 1
The Ottawa Hospital Academic Medical AssociationEarly Phase 1
Ottawa Hospital Research InstituteEarly Phase 1

See all cephalexin clinical trials

Pharmacology for cephalexin
Medical Subject Heading (MeSH) Categories for cephalexin

US Patents and Regulatory Information for cephalexin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 065444-002 Aug 28, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Apothecon CEPHALEXIN cephalexin CAPSULE;ORAL 062974-001 Nov 23, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Lilly KEFLET cephalexin TABLET;ORAL 062745-001 Dec 1, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Yoshitomi CEPHALEXIN cephalexin CAPSULE;ORAL 062871-001 Jul 5, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Barr CEPHALEXIN cephalexin TABLET;ORAL 062826-001 Aug 17, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Teva CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 062767-001 Jun 16, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Teva CEPHALEXIN cephalexin CAPSULE;ORAL 062702-001 Feb 13, 1987 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Johnson and Johnson
Dow
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.